Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene
Authors
Keywords
-
Journal
BMC CANCER
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2010-10-09
DOI
10.1186/1471-2407-10-540
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of Phase II Drug Metabolizing Enzymes in Cancer Chemoprevention
- (2012) Snehasis Jana et al. CURRENT DRUG METABOLISM
- Cancer Chemoprevention Mechanisms Mediated Through the Keap1–Nrf2 Pathway
- (2010) John D. Hayes et al. ANTIOXIDANTS & REDOX SIGNALING
- Attenuation of NF-κB and activation of Nrf2 signaling by 1,2,4-triazine derivatives, protects neuron-like PC12 cells against apoptosis
- (2010) Solaleh Khoramian Tusi et al. APOPTOSIS
- Fragrant Unsaturated Aldehydes Elicit Activation of the Keap1/Nrf2 System Leading to the Upregulation of Thioredoxin Expression and Protection Against Oxidative Stress
- (2009) Hiroshi Masutani et al. ANTIOXIDANTS & REDOX SIGNALING
- Citrus auraptene suppresses cyclin D1 and significantly delays N-methyl nitrosourea induced mammary carcinogenesis in female Sprague-Dawley rats
- (2009) Prasad Krishnan et al. BMC CANCER
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Plasma Protein Carbonyls and Breast Cancer Risk in Sisters Discordant for Breast Cancer from the New York Site of the Breast Cancer Family Registry
- (2009) J. Zipprich et al. CANCER RESEARCH
- Dietary olive oil and corn oil differentially affect experimental breast cancer through distinct modulation of the p21Ras signaling and the proliferation-apoptosis balance
- (2009) M. Solanas et al. CARCINOGENESIS
- Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice
- (2009) Melinda S. Yates et al. CARCINOGENESIS
- Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer
- (2009) PS Patel et al. INDIAN JOURNAL OF CANCER
- Targeting NRF2 signaling for cancer chemoprevention
- (2009) Mi-Kyoung Kwak et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Targeting Transcription Factors for Cancer Prevention--the Case of Nrf2
- (2008) N. H. Colburn et al. Cancer Prevention Research
- Loss of Keap1 Function Activates Nrf2 and Provides Advantages for Lung Cancer Cell Growth
- (2008) T. Ohta et al. CANCER RESEARCH
- RNAi-Mediated Silencing of Nuclear Factor Erythroid-2-Related Factor 2 Gene Expression in Non-Small Cell Lung Cancer Inhibits Tumor Growth and Increases Efficacy of Chemotherapy
- (2008) A. Singh et al. CANCER RESEARCH
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma
- (2008) D F Peng et al. GUT
- Dibenzoylmethane Activates Nrf2-Dependent Detoxification Pathway and Inhibits Benzo(a)pyrene Induced DNA Adducts in Lungs
- (2008) R. Thimmulappa et al. Medicinal Chemistry
- Dual roles of Nrf2 in cancer
- (2008) A LAU et al. PHARMACOLOGICAL RESEARCH
- Comparison of citrus coumarins on carcinogen-detoxifying enzymes in Nrf2 knockout mice
- (2008) Misty Prince et al. TOXICOLOGY LETTERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started